IGF1 and neoplasm: In agreement with this, the analyses performed using the GEPIA tool confirm that in tumor patients the expression of PTCH1 and IGF1 genes is lower than in normal patients, suggesting therefore a downregulation in a more aggressive cell state (Figures 8a and 8b).